Cargando…

Development of Analytical Quality by Design Compliant Chaotropic Chromatography Method for Ziprasidone and Its Five Impurities Determination

In this study, an AQbD-compliant chaotropic chromatography method for ziprasidone and the determination of its five impurities was developed. The influence of critical method parameters (initial and final methanol fraction in the mobile phase, gradient duration) on the set of selected critical metho...

Descripción completa

Detalles Bibliográficos
Autores principales: Rmandić, Milena, Vasilić, Đorđe, Rašević, Marija, Zečević, Mira, Otašević, Biljana, Protić, Ana, Malenović, Anđelija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534573/
https://www.ncbi.nlm.nih.gov/pubmed/37765104
http://dx.doi.org/10.3390/ph16091296
_version_ 1785112426404904960
author Rmandić, Milena
Vasilić, Đorđe
Rašević, Marija
Zečević, Mira
Otašević, Biljana
Protić, Ana
Malenović, Anđelija
author_facet Rmandić, Milena
Vasilić, Đorđe
Rašević, Marija
Zečević, Mira
Otašević, Biljana
Protić, Ana
Malenović, Anđelija
author_sort Rmandić, Milena
collection PubMed
description In this study, an AQbD-compliant chaotropic chromatography method for ziprasidone and the determination of its five impurities was developed. The influence of critical method parameters (initial and final methanol fraction in the mobile phase, gradient duration) on the set of selected critical method attributes (t(_imp. V), t(_imp. V) − t(_imp. I), S and <W(USP)>) was studied by Box–Behnken design. The errors resulting from the calculation of the model coefficients were propagated to the selected responses by Monte Carlo simulations, and their predictive distribution was obtained. The design space was computed (π ≥ 80%), and a working point was selected: initial methanol fraction 38.5%, final methanol fraction 77.5%, and gradient duration 16.25 min. Furthermore, the quantitative robustness of the developed method was tested using the Plackett–Burman design. P(_imp II) and P(_imp V) were found to be significantly affected, the first by mobile phase flow rate and the second by gradient duration. Finally, the method was validated, and its reliability for routine quality control in capsules was confirmed.
format Online
Article
Text
id pubmed-10534573
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105345732023-09-29 Development of Analytical Quality by Design Compliant Chaotropic Chromatography Method for Ziprasidone and Its Five Impurities Determination Rmandić, Milena Vasilić, Đorđe Rašević, Marija Zečević, Mira Otašević, Biljana Protić, Ana Malenović, Anđelija Pharmaceuticals (Basel) Article In this study, an AQbD-compliant chaotropic chromatography method for ziprasidone and the determination of its five impurities was developed. The influence of critical method parameters (initial and final methanol fraction in the mobile phase, gradient duration) on the set of selected critical method attributes (t(_imp. V), t(_imp. V) − t(_imp. I), S and <W(USP)>) was studied by Box–Behnken design. The errors resulting from the calculation of the model coefficients were propagated to the selected responses by Monte Carlo simulations, and their predictive distribution was obtained. The design space was computed (π ≥ 80%), and a working point was selected: initial methanol fraction 38.5%, final methanol fraction 77.5%, and gradient duration 16.25 min. Furthermore, the quantitative robustness of the developed method was tested using the Plackett–Burman design. P(_imp II) and P(_imp V) were found to be significantly affected, the first by mobile phase flow rate and the second by gradient duration. Finally, the method was validated, and its reliability for routine quality control in capsules was confirmed. MDPI 2023-09-14 /pmc/articles/PMC10534573/ /pubmed/37765104 http://dx.doi.org/10.3390/ph16091296 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rmandić, Milena
Vasilić, Đorđe
Rašević, Marija
Zečević, Mira
Otašević, Biljana
Protić, Ana
Malenović, Anđelija
Development of Analytical Quality by Design Compliant Chaotropic Chromatography Method for Ziprasidone and Its Five Impurities Determination
title Development of Analytical Quality by Design Compliant Chaotropic Chromatography Method for Ziprasidone and Its Five Impurities Determination
title_full Development of Analytical Quality by Design Compliant Chaotropic Chromatography Method for Ziprasidone and Its Five Impurities Determination
title_fullStr Development of Analytical Quality by Design Compliant Chaotropic Chromatography Method for Ziprasidone and Its Five Impurities Determination
title_full_unstemmed Development of Analytical Quality by Design Compliant Chaotropic Chromatography Method for Ziprasidone and Its Five Impurities Determination
title_short Development of Analytical Quality by Design Compliant Chaotropic Chromatography Method for Ziprasidone and Its Five Impurities Determination
title_sort development of analytical quality by design compliant chaotropic chromatography method for ziprasidone and its five impurities determination
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534573/
https://www.ncbi.nlm.nih.gov/pubmed/37765104
http://dx.doi.org/10.3390/ph16091296
work_keys_str_mv AT rmandicmilena developmentofanalyticalqualitybydesigncompliantchaotropicchromatographymethodforziprasidoneanditsfiveimpuritiesdetermination
AT vasilicđorđe developmentofanalyticalqualitybydesigncompliantchaotropicchromatographymethodforziprasidoneanditsfiveimpuritiesdetermination
AT rasevicmarija developmentofanalyticalqualitybydesigncompliantchaotropicchromatographymethodforziprasidoneanditsfiveimpuritiesdetermination
AT zecevicmira developmentofanalyticalqualitybydesigncompliantchaotropicchromatographymethodforziprasidoneanditsfiveimpuritiesdetermination
AT otasevicbiljana developmentofanalyticalqualitybydesigncompliantchaotropicchromatographymethodforziprasidoneanditsfiveimpuritiesdetermination
AT proticana developmentofanalyticalqualitybydesigncompliantchaotropicchromatographymethodforziprasidoneanditsfiveimpuritiesdetermination
AT malenovicanđelija developmentofanalyticalqualitybydesigncompliantchaotropicchromatographymethodforziprasidoneanditsfiveimpuritiesdetermination